2005年 |
1. |
Kosugi N, Ebihara Y, Nakahata T, Saisho H, Asano S, Tojo A:
CD34+CD7+ leukemic progenitor cells may be involved in maintenance
and clonal evolution of chronic myeloid leukemia.
Clin Cancer Res. 11:505-11, 2005 |
|
2004年 |
1. |
Tsuchimoto D, Tojo A, Asano S:
A mechanism of transcriptional regulation of the CSF-1 gene by interferon-gamma.
Immunol Invest. 33:397-405, 2004 |
2. |
Cho SG, Shuto Y, Soda Y, Nakazaki Y, Izawa K,
Uchimaru K, Takahashi S, Tani K, Tojo A, Asano S:
Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched,
T-cell depleted, nonmyeloablative bone marrow transplantation.
Exp Hematol. 32:1246-54, 2004 |
3. |
Tani K, Azuma M, Nakazaki Y, Oyaizu N, Hase H,
Ohata J, Takahashi K, OiwaMonna M, Hanazawa K, Wakumoto Y, Kawai K, Noguchi M, Soda Y,
Kunisaki K, Watari K, Takahashi S, Machida U, Satoh N, Tojo A, Maekawa T, Eriguchi M,
Tomikawa S, Tahara H, Inoue Y, Yoshikawa H, Yamada Y, Iwamoto A, Hamada H, Yamashita N,
Okumura K, Kakizoe T, Akaza H, Fujime M, Clift S, Ando D, Mulligan R, Asano S:
Phase I Study of Autologous Tumor Vaccines Transduced with the GM-CSF Gene
in Four Patients with Stage IV Renal Cell Cancer in Japan:
Clinical and Immunological Findings. Mol Ther. 10:799-816, 2004 |
4. |
Izawa K, Tani K, Nakazaki Y, Hibino H, Sugiyama H,
Kawasaki A, Sasaki E, Nishioka C, Ishii H, Soda Y, Yagita H, Tanioka Y, Tojo A, Asano S:
Hematopoietic ativity of common marmoset CD34+ cells by a novel monoclonal antibody MA24.
Exp Hematol. 32:843-51, 2004 |
5. |
Harata M, Soda Y, Tani K, Ooi J, Takizawa T,
Chen M, Bai Y, Izawa K, Kobayashi S, Tomonari A, Nagamura F, Takahashi S, Uchimaru K,
Iseki T, Tsuji T, Takahashi TA, Sugita K, Nakazawa S, Tojo A, Maruyama K, Asano S:
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia
chromosome-positive acute lymphoblastic leukemia cells. Blood. 104:1442-9, 2004 |
6. |
Soda Y, Tani K, Bai Y, Saiki M, Chen M, Izawa K,
Kobayashi S, Takahashi S, Uchimaru K, Kuwabara T, Warashina M, Tanabe T, Miyoshi H,
Sugita K, Nakazawa S, Tojo A, Taira K, Asano S:
A novel maxizyme vector targeting a bcr-abl fusion gene induced specific cell death
in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood. 104:356-63, 2004 |
7. |
Oshima Y, Tojo A, Fujimua A, Niho Y, Asano S:
Potent receptor-mediated cytotoxicity of granulocyte colony-stimulating factor-Pseudomonas
exotoxin A fusion protein against myeloid leukemia cells.
Biochem Biophys Res Commun. 319:582-9, 2004 |
8. |
Morishita M, Uchimaru K, Sato K, Yamashita S,
Kanematsu T, Yamashita N,
Thyroglobulin-pulsed human monocyte-derived dendritic cells induce CD4+T cell activation.
Int J Mol Med. 13:33-9, 2004 |
9. |
Kobayashi S, Kaneko Y, Seino K, Yamada Y, Motohashi Y,
Koike J, Sugaya K, Kuriyama T, Asano S, Tsuda T, Wakao H, Harada M, Kojo S, Nakayama T,
Taniguchi M. Impaired IFN-γ production of Vα24 NKT cells in non-remitting sarcoidosis.
Int Immunol. 16:215-22, 2004 |
|
2003年 |
1. |
Nagamura F, Takahashi T, Takeuchi M, Iseki T,
Ooi J, Tomonari A, Uchimaru K, Takahashi S, Tojo A, Tani K, Asano S:
Effect of cyclophosphamide on serum cyclosporine levels at the conditioning of
hematopoietic stem cell transplantation. Bone Marrow Transplant. 32:1051-8, 2003 |
2. |
Zheng Y, Watanabe N, Nagamura-Inoue T, Igura K,
Nagayama H, Tojo A, Tanosaki R, Takaue Y, Okamoto S, Takahashi T.A:
Ex vivo manipulation of umbilical cord-derived hematopoietic stem⁄progenitor
cells with recombinant human stem cell factor can up-regulate levels of homing-essential
molecules to increase their transmigratory potential. Exp Hematol. 31:1237-46, 2003 |
3. |
Bai Y, Soda Y, Izawa K, Tanabe T, Kang X, Tojo A,
Hoshino H, Miyoshi H, Asano S, Tani K:
Effective transduction and stable transgene expression in human blood cells by
a third-generation lentiviral vector. Gene Therapy. 10:1446-57. 2003 |
4. |
Nagayama H, Sato K, Morishita M, Uchimaru K, Oyaizu N,
Inazawa T, Yamasaki T, Enomoto M, Nakaoka T, Nakamura T, Maekawa T, Yamamoto A, Shimada S,
Saida T, Kawakami Y, Asano S, Tani K, Takahashi TA, Yamashita N:
Results of phase I clinical study using autologous tumor-lysate pulsed monocyte-derived
mature dendritic cell vaccinations for stage IV malignant melanoma patients combined with
low dose interleukin-2. Melanoma Res. 13:1-10, 2003 |
5. |
Takahashi S, Mok H, Parrott MB, Marini FC,
Andreef M, Brenner MK, Barry MA.
Selection of chronic lymphocytic leukemia (CLL) binding peptides.
Cancer Res. 63:5213-7, 2003 |
6. |
Oshima K, Kawasaki H, Soda Y, Tani K, Asano S, Taira K:
Maxizyme and small hairpin-type RNAs that are driven by a tRNA promoter specifically cleaves
a chimeric gene associated with leukemia in vitro and in vivo. Cancer Res. 63:6809-14, 2003 |
7. |
Biagi E, Yvon E, Dotti G, Amrolia PJ, Takahashi S,
DeSombre C, Popat U, MD, Rice L, Marini F, Andreeff M, Brenner MK, Rousseau RF.
Induction of Functional Human CD40 Ligand (hCD40L) Expression on B-Chronic Lymphocytic
Leukemia Cells. Hum Gene Ther. 14:545-59, 2003 |
|
2002年 |
1. |
Iijima Y, Okuda K, Tojo A, Tri NK, Setoyama M,
Sakaki Y, Asano S, Tokunaga K, Kruh GD, Sato Y:
Transformation of Ba⁄F3 cells and Rat-1 cells by ETV6⁄ARG. Oncogene.
21:4374-83, 2002 |
2. |
Motohashi S, Kobayashi S, Ito T, Magara KK,
Mikuni O, Kamada N, Iizasa T, Nakayama T, Fujisawa T, Taniguchi M:
Preserved interferon-α production of circulating Vα24 NKT cells in primary
lung cancer. Int J Cancer. 102:159-65, 2002 |
3. |
Ohata J, Sakurai J, Saito K, Tani K, Asano S, Azuma M:
Differential graft-versus-leukemia effect by CD28 and CD40 co-stimulatory blockade
after graft-versus-host disease prophylaxis. Clin Exp Immunol. 129: 61-8, 2002 |
|
2001年 |
1. |
Hibino H, Tani K, Sugiyama H, Suzuki S, Wu M-S,
Izawa K, Hase H, Nakazaki Y, Tanabe T, Ooi J, Iseki T, Tojo A, Saitoh I, Tanioka Y, Asano S:
Haematopoietic progenitor cells from the common marmoset as targets of gene transduction
by retroviral and adenoviral vectors. Eur J Haematol. 66: 272-80, 2001 |
2. |
Rousseau RF, Hirschmann-Jax C, Takahashi S, Brenner MK.
Cancer vaccine. Hematology⁄Oncology Clinics of North America. 154:741-73, 2001. |
3. |
Dotti G, Savoldo B, Takahashi S, Goltsova T, Rill D, Rooney C, Brennser M:
Adenovector induced expression of human-CD40L by multiple myeloma cells:
a model for immunotherapy. Exp Hematol. 29:952-61, 2001 |
4. |
Takahashi S, Yotnda P, Rousseau RF, Mei Z, Smith S,
Rill D, Youne A, Brenner MK:
Transgenic expression of CD40L and Interleukin-2 induces
an autologous anti-tumor immune response in patients with non-Hodgkin lymphoma.
Cancer Gene Ther. 8:378-87, 2001 |
5. |
Takahashi S, Rousseau RF, Yotnda P, Mei Z, Dotti G,
Rill D, Hurwitz R, Marini F, Andreeff M, Brenner MK.
Autologous antileukemic immune responses induced by chronic lymphocytic leukemia B cells
expressing the CD40 ligand and interleukin-2 transgenes. Hum Gene Ther. 12:659-70, 2001 |
|
2000年 |
1. |
Wu M-S, Tani K, Sugiyama H, Hibino H, Izawa K,
Tanabe T, Nakazaki Y, Ishii H, Ohashi J, Hohjoh H, Iseki T, Tojo A, Nakamura Y, Tanioka Y, Tokunaga K, Asano S:
MHC (Major Histocompatibility Complex)-DRB Genes and polymorphisms in common marmoset.
J Mol Evol. 51:214-22, 2000 |
2. |
Watari K, Tojo A, Nagamura-Inoue T, Matsuoka M,
Irie S, Tani K, Yamada Y, and Asano S:
Hyperfunction of neutrophils in a BCR⁄ABL-negative chronic myeloid leukemia:
A case report with in vitro studies. Cancer. 89:551-6, 2000 |
3. |
Hase H, Tani K, Nagayama H, Watari K, Takahashi S,
Ooi J, Shirafuji N, Iseki T, Nakazaki Y, Yamashita T, Nakamura T, Masunaga A, Maekawa T,
Tojo A, Asano S: TCR-Vβ repertoire analysis with RT-PCR was useful for the early
detection of pulmonary relapsed T cell lymphoma after autologous peripheral blood stem
cell transplantation. Am J Hematol. 64:124-7, 2000 |
4. |
Machida U, Tojo A, Takahashi S, Iseki T, Ooi J, Nagayama H,
Shirafuji N, Mori S-I, Wada Y, Ogami K, Yamada Y, Sakamaki H, Maekawa T, Tani K, Asano S:
The effect of G-CSF administration in healthy donors before bone marow harvesting.
Br J Haematol. 108:747-53, 2000 |
5. |
Kosugi N, Tojo A, Shinzaki H, Nagamura-Inoue T, Asano S:
The preferential expression of CD34 and CD7 in myeloid blast crisis in chronic myeloid leukemia.
Blood. 95:2188-9, 2000 |
6. |
Watari K, Tojo A, Nagamura-Inoue T, Nagamura F, Takeshita A,
Fukushima T, Motoji T, Tani K, Asano S:
Identification of a melanoma antigen, PRAME, as a BCR-ABL-inducible gene. FEBS Letters.
466:367-71, 2000 |
7. |
Oshima Y, Tojo A, Niho Y, Asano S:
Biological activity of human granulocyte colony-stimulating factor with
a modified C-terminus. Biochem Biophys Res Commun. 267:924-7, 2000 |
8. |
Tanabe T, Kuwabara T, Warashima M, Tani K, Taira K, Asano S:
Oncogene inactivation in a mouse model:
tissue invasion by leukemic cells is stalled by loading them with a designer ribozyme.
Nature. 406:473-4, 2000 |
9. |
Soda Y, Jinno A, Tanaka Y, Akagi T, Shimotohno K, Hoshino H:
Rapid tumor formation and development of neutropenia and splenomegaly in nude mice transplanted
with human cells expressing human T cell leukemia virus type I or Tax1. Leukemia. 14:1467-76, 2000 |
|